Literature DB >> 20029951

The number of people with sickle-cell disease in the United States: national and state estimates.

David C Brousseau, Julie A Panepinto, Mark Nimmer, Raymond G Hoffmann.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20029951     DOI： 10.1002/ajh.21570

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  121 in total

1.  VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Authors:  Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Amy D Shapiro; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Jeanne M Lusher; Margaret V Ragni; Robert R Montgomery
Journal:  Blood       Date:  2011-12-23       Impact factor: 22.113

Review 2.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

3.  Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease.

Authors:  Robert M Cronin; Manshu Yang; Jane S Hankins; Jeannie Byrd; Brandi M Pernell; Adetola Kassim; Patricia Adams-Graves; Alexis A Thompson; Karen Kalinyak; Michael DeBaun; Marsha Treadwell
Journal:  Hematology       Date:  2020-12       Impact factor: 2.269

4.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

5.  Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

Authors:  Maureen M Okam; Erica B Esrick; Elyse Mandell; Federico Campigotto; Donna S Neuberg; Benjamin L Ebert
Journal:  Blood       Date:  2015-06-04       Impact factor: 22.113

6.  Ambulatory quality indicators to prevent infection in sickle cell disease.

Authors:  Lauren M Beverung; David Brousseau; Raymond G Hoffmann; Ke Yan; Julie A Panepinto
Journal:  Am J Hematol       Date:  2014-03       Impact factor: 10.047

Review 7.  Key Components of Pain Management for Children and Adults with Sickle Cell Disease.

Authors:  Amanda M Brandow; Michael R DeBaun
Journal:  Hematol Oncol Clin North Am       Date:  2018-06       Impact factor: 3.722

8.  Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.

Authors:  Sophie Lanzkron; C Patrick Carroll; Carlton Haywood
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

9.  Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case-control study.

Authors:  Regina D Crawford; Charles R Jonassaint
Journal:  J Adv Nurs       Date:  2015-08-20       Impact factor: 3.187

10.  National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.

Authors:  Timothy L McCavit; Lei Xuan; Song Zhang; Glenn Flores; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2012-11-14       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.